BioSpace News Archive

Business

Wugen Ramps Up Off-the-Shelf Gene Therapies to Fight Cancer

The “Woogies” at Wugen have been busy these past three years. BioSpace sat down with CEO John McKearn, Ph.D. to find up what his company has been up to.

January 26, 2021
·
3 min read
·
Kate Goodwin
Drug Development

Over-the-Counter COVID Nasal Spray Could Be Effective

An in vitro study conducted by scientists from Northwestern University and Utah State University concluded COVID nasal spray as an effective medicine. Learn more here.

January 26, 2021
·
3 min read
·
Alex Keown
Job Trends

Novartis Shares Down Following Disappointing 4Q Report

Novartis shares were down by 4.4% as the market opened, following the announcement on its earnings call of a disappointing $2.1 billion in net profits and $0.92 earnings per share for 4Q20, below most investor estimates.

January 26, 2021
·
2 min read
·
Mark Zipkin
Drug Development

Regeneron’s COVID-19 Antibody Cocktail Works as ‘Passive Vaccine’

Regeneron announced positive initial data from its ongoing Phase III trial of its antibody cocktail, REGEN-COV, as a passive vaccine to prevent COVID-19 in people at high risk of infection from household exposure.

January 26, 2021
·
3 min read
·
Mark Terry
Business

Combination Regimen Reduces Pain for Women with Endometriosis

Findings from a Phase III long-term extension study show a once-daily therapy consisting of relugolix with estradiol and norethindrone acetate leads to clinically meaningful reductions in menstrual pain and non-menstrual pelvic pain over one year in women with endometriosis.

January 26, 2021
·
2 min read
·
Brandon May
Drug Development

2021 Biopharma Update on the Novel Coronavirus: January 26

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.

January 26, 2021
·
4 min read
·
BioSpace Editorial Staff
Business

Nirogy Raises $16.5 Million to Focus on Transporter Proteins

Nirogy Therapeutics, based in Boston, launched with a $16.5 million Series A financing round. The round was co-led by Santé Ventures and Sporos.

January 26, 2021
·
3 min read
·
Mark Terry
BioCapital

COVID-19 Variants: More Infectious, More Lethal, but Vaccines Could Still Be Effective

British scientists suggested last week that the U.K. variant may be approximately 30% more lethal than the most common strain that came out of China. But they’re not completely sure of this yet.

January 26, 2021
·
4 min read
·
Mark Terry
Are Gene Therapies the Medicine of the Future?

Gene therapies offer great reward in the form of treating various devastating diseases, but there are also significant risks.

January 26, 2021
·
4 min read
·
Alex Keown
Drug Development

Data Shows Eli Lilly Antibody Combo Cuts COVID-19 Hospitalizations, Deaths

New Phase III efficacy data from Eli Lilly showed that a combination of two experimental neutralizing antibodies, bamlanivimab and etesevimab, met the primary endpoint of reduced hospitalizations and deaths from COVID-19.

January 26, 2021
·
2 min read
·
Mark Zipkin